Menu
GeneBe

rs61745125

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_144670.6(A2ML1):​c.3252C>T​(p.His1084=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0053 in 1,614,110 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0047 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 44 hom. )

Consequence

A2ML1
NM_144670.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.802
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 12-8858090-C-T is Benign according to our data. Variant chr12-8858090-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 241900.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-8858090-C-T is described in Lovd as [Likely_benign]. Variant chr12-8858090-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.802 with no splicing effect.
BS2
High AC in GnomAd4 at 716 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
A2ML1NM_144670.6 linkuse as main transcriptc.3252C>T p.His1084= synonymous_variant 26/36 ENST00000299698.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
A2ML1ENST00000299698.12 linkuse as main transcriptc.3252C>T p.His1084= synonymous_variant 26/361 NM_144670.6 P1A8K2U0-1
A2ML1ENST00000541459.5 linkuse as main transcriptc.1902C>T p.His634= synonymous_variant 15/252
A2ML1ENST00000539547.5 linkuse as main transcriptc.1779C>T p.His593= synonymous_variant 15/252 A8K2U0-2

Frequencies

GnomAD3 genomes
AF:
0.00470
AC:
716
AN:
152182
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0191
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00623
Gnomad OTH
AF:
0.00479
GnomAD3 exomes
AF:
0.00495
AC:
1233
AN:
249320
Hom.:
5
AF XY:
0.00479
AC XY:
648
AN XY:
135276
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00226
Gnomad FIN exome
AF:
0.0191
Gnomad NFE exome
AF:
0.00574
Gnomad OTH exome
AF:
0.00496
GnomAD4 exome
AF:
0.00536
AC:
7839
AN:
1461810
Hom.:
44
Cov.:
32
AF XY:
0.00524
AC XY:
3811
AN XY:
727196
show subpopulations
Gnomad4 AFR exome
AF:
0.000836
Gnomad4 AMR exome
AF:
0.00127
Gnomad4 ASJ exome
AF:
0.00107
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00252
Gnomad4 FIN exome
AF:
0.0179
Gnomad4 NFE exome
AF:
0.00563
Gnomad4 OTH exome
AF:
0.00467
GnomAD4 genome
AF:
0.00470
AC:
716
AN:
152300
Hom.:
3
Cov.:
32
AF XY:
0.00520
AC XY:
387
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.000914
Gnomad4 AMR
AF:
0.00229
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.0191
Gnomad4 NFE
AF:
0.00623
Gnomad4 OTH
AF:
0.00474
Alfa
AF:
0.00514
Hom.:
0
Bravo
AF:
0.00307
Asia WGS
AF:
0.00144
AC:
6
AN:
3478
EpiCase
AF:
0.00393
EpiControl
AF:
0.00427

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2023A2ML1: BP4, BP7 -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 13, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 02, 2019- -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 14, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
A2ML1-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesSep 16, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
2.0
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61745125; hg19: chr12-9010686; API